VAMP

Description: VAMP is a tetrapeptide that acts as a competitive dipeptidyl peptidase IV (DPP-IV) inhibitor, exhibiting an IC50 of 1.00 µM and a Kd of 6.89 µM. It effectively targets the DPP-IV-GLP-1 axis and is utilized in the research of type 2 diabetes. Target: Proteasome. Smiles: C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](C(C)C)N